Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues
May 07, 2021 at 15:55 PM EDT
Pfizer's CEO said the waiver proposal "will unleash a scramble for the critical inputs we require in order to make a safe and effective vaccine.'
